Mirum Pharmaceuticals Inc (MIRM)
R&D Expense Growth
-7.54%
Quarterly · Period ending:
MIRM R&D Expense Growth
Latest reported-7.54%period ending
Latest reported-7.54%period ending
MIRM Quarterly R&D Growth (QoQ) (0.00% → -7.54%)
Latest values, visible window
High-resolution chart · PNG
MIRM r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -7.5396% | |
| 91.5785% | |
| 18.9642% | |
| -6.7445% | |
| 0.05% | |
| 4.5837% | |
| 38.8395% | |
| -2.9444% | |
| 1.3966% | |
| 4.1603% | |
| 18.4478% | |
| 18.6651% | |
| -6.5356% | |
| -24.2951% | |
| 18.6444% | |
| 3.0867% | |
| 5.5795% | |
| -13.2745% | |
| -8.8478% | |
| -13.0592% | |
| -8.0925% | |
| 28.285% | |
| 85.9735% | |
| -13.8561% | |
| 7.0069% | |
| 20.5841% | |
| 18.2663% | |
| 4.9185% | |
| 138.3097% | |
| -80.7242% | |
| 840,850% | |
| 0% |